{
    "nctId": "NCT02773095",
    "briefTitle": "Evaluation of Novartis Access; a Non-communicable Disease (NCD) Access Initiative",
    "officialTitle": "Evaluation of Novartis Access; a Non-communicable Disease (NCD) Access Initiative",
    "overallStatus": "COMPLETED",
    "conditions": "Cardiovascular Disease, Diabetes Type II, Breast Cancer, Asthma",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "HEALTH_SERVICES_RESEARCH",
    "enrollmentCount": 966,
    "primaryOutcomeMeasure": "Availability of Novartis Access medicines and equivalents at public and private non-profit facilities: proportion of Novartis Access NCD medicines and equivalents that a facility has in stock on the day of data collection",
    "eligibilityCriteria": "Household Inclusion Criteria:\n\n* At least one household member diagnosed and prescribed treatment for an NCD condition targeted by Novartis Access (asthma; diabetes; breast cancer; hypertension)\n* Eligible household members must be at least 18 years of age to participate\n\nHousehold Exclusion Criteria:\n\n* Households who are unwilling to provide informed consent\n* Households that plan to move from their location during the two year period of the study",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}